Laufey Tryggvadóttír
A5086006915- Cancer Risks and Factors
- Global Cancer Incidence and Screening
- BRCA gene mutations in cancer
- Childhood Cancer Survivors' Quality of Life
- Occupational and environmental lung diseases
- Acute Lymphoblastic Leukemia research
- Colorectal Cancer Screening and Detection
- Nutritional Studies and Diet
- Genetic factors in colorectal cancer
- Air Quality and Health Impacts
- Carcinogens and Genotoxicity Assessment
- Cervical Cancer and HPV Research
- Cancer Genomics and Diagnostics
- Cutaneous Melanoma Detection and Management
- Esophageal Cancer Research and Treatment
- Nutrition, Genetics, and Disease
- Ovarian cancer diagnosis and treatment
- Epigenetics and DNA Methylation
- Genetic Associations and Epidemiology
- Multiple and Secondary Primary Cancers
- DNA Repair Mechanisms
- Nonmelanoma Skin Cancer Studies
- Gastroesophageal reflux and treatments
- Cancer-related Molecular Pathways
- Endometrial and Cervical Cancer Treatments
Icelandic Cancer Society
2015-2024
University of Iceland
2015-2024
London School of Hygiene & Tropical Medicine
2016-2022
London Cancer
2021-2022
Norwegian University of Science and Technology
2020
Karolinska University Hospital
2020
Karolinska Institutet
2012-2020
Aarhus University Hospital
2019
Cancer Registry of Norway
2002-2018
Finnish Cancer Registry
2011-2018
We present up to 45 years of cancer incidence data by occupational category for the Nordic populations. The study covers 15 million people aged 30–64 in 1960, 1970, 1980/1981 and/or 1990 censuses Denmark, Finland, Iceland, Norway and Sweden, 2.8 incident cases diagnosed these a follow-up until about 2005. was undertaken as cohort with linkage individual records based on personal identity codes used all countries.In censuses, information occupation each person provided through free text...
Multiple genetic loci confer susceptibility to breast and ovarian cancers. We have previously developed a model (BOADICEA) under which cancer is explained by mutations in BRCA1 BRCA2, as well the joint multiplicative effects of many genes (polygenic component). now updated BOADICEA using additional family data from two UK population-based studies BRCA2 carriers identified 22 or cancer. The combined set includes 2785 families (301 positive 236 positive). Incidences were smoothed locally...
Background: The Nordic Cancer Registries are among the oldest population-based registries in world, with more than 60 years of complete coverage what is now a combined population 26 million. However, despite being source substantial number studies, there no published paper comparing different registries. Therefore, we did systematic review to identify similarities and dissimilarities Registries, which could possibly explain some differences cancer incidence rates across these...
Melanoma is a significant health problem in Caucasian populations. The most recently available data from cancer registries often have delay of several months up to few years and they are generally not easily accessible.To assess recent age- sex-specific trends melanoma incidence make predictions for 2010 2015.A retrospective registry-based analysis was performed with 29 European registries. Most them had 1990 2006/7. World-standardized rates (WSR) the estimated annual percentage change...
The quadrivalent human papillomavirus (qHPV) vaccine prevented HPV type-related infection and disease in young women the 4-year FUTURE II efficacy study (NCT00092534). We report long-term effectiveness immunogenicity at end of 14 years follow-up after enrollment II.Young (16-23 age) from Denmark, Iceland, Norway, Sweden who received three qHPV doses during randomized, double-blind, placebo-controlled base were followed for an additional ≥10 through national registries. Tissue samples...
Methods. We conducted a population-based cross-sectional study in 69,147 women (18–45 years of age) randomly chosen from the general population Denmark, Iceland, Norway, and Sweden. Information on clinically diagnosed genital warts lifestyle habits was collected using questionnaire.
Mutations in the BRCA2 gene are associated with an increased risk of prostate cancer, but it is not known whether they progression disease. We compared cancer-specific survival, disease stage, and tumor grade between cancer patients carrying Icelandic 999del5 founder mutation noncarriers.Using population-based registries, we identified all 596 who were diagnosed Iceland during 1955 through 2004 among 29603 male relatives unselected breast probands. status could be determined for 527 (88.4%)....
Trends in incidence and mortality rates of prostate cancer were analyzed using data from the national registries Denmark, Finland, Iceland, Norway, Sweden. Joinpoint regression models used to quantify temporal trends for period 1980 2004. Incidence increasing similar Nordic countries during 1980s. Around 1990, a more rapid increase began all except where an was seen 5 years later. In 2001, Denmark half those other countries, but varied only marginally among countries. Mean annual declines...